Faculty profile

Igor Novitzky-Basso

Back to faculty

Assistant ProfessorDepartment of MedicineUniversity of Toronto

Igor Novitzky-Basso

Assistant Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
52 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

387

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2026
Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia.
British journal of haematology · 2026
ATP2B1 expression identifies human hematopoietic stem cells with superior repopulation and self-renewal.
Proceedings of the National Academy of Sciences of the United States of America · 2026

All 55 publications

55 publications.

Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study.

Hall VG, Alexander AA, Mavandadnejad F, Kern-Smith M, Dang X, Kang R, Humar S, Winichakoon P, Johnstone R, Aversa M, Novitzky-Basso I, Lavoie PM, Kumar D, Mattsson J, Ferreira VH

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases202612 citationsOpen Access

DOI: 10.1016/j.cmi.2025.09.013 PMID: 41016596

Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia.

Desai N, Althobaiti M, Chen C, Al-Shaibani E, Moya TA, Novitzky-Basso I, Pasic I, Michelis FV, Kim DD, Kumar R, Mattsson J, Law AD, Viswabandya A

British journal of haematology20263 citations

DOI: 10.1111/bjh.70380 PMID: 41747740

ATP2B1 expression identifies human hematopoietic stem cells with superior repopulation and self-renewal.

Varesi A, Nagree MS, Di Biasio I, Zeng AGX, Shah S, Zhang M, Kim H, Murison A, Badami R, Gan O, Jin L, McLeod J, Abraham SA, Minden MD, Arruda A, Novitzky-Basso I, Mattsson J, Dick JE, Xie SZ

Proceedings of the National Academy of Sciences of the United States of America20262 citationsOpen Access

DOI: 10.1073/pnas.2604380123 PMID: 42085155

Frailty as a Prognostic Factor in Younger Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.

Rodriguez-Rodriguez S, Salas MQ, Desai N, Al-Shaibani E, Novitzky-Basso I, Pasic I, Viswabandya A, Michelis FV, Mattsson J, Kim DDH, Kumar R, Moya TA

Transplantation and cellular therapy20261 citations

DOI: 10.1016/j.jtct.2026.01.026 PMID: 41571188

Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation.

Desai N, Rodriguez-Rodriguez S, Chen C, Al-Shaibani E, Alfaro Moya T, Novitzky-Basso I, Pasic I, Michelis FV, Viswabandya A, Kim DDH, Kumar R, Mattsson J, Law AD

JCO oncology practice20261 citations

DOI: 10.1200/op-25-01308 PMID: 42372210

Herpes Zoster Frequency and Adjuvanted Recombinant Zoster Vaccination after Allogeneic Hematopoietic Cell Transplantation.

Hall VG, Chiarello C, Remberger M, Kumar D, Pasic I, Kim DDH, Kumar R, Viswabandya A, Michelis FV, Law A, Gerbitz A, Humar S, Lam W, Novitzky-Basso I, Mattsson J

Transplantation and cellular therapy20261 citations

DOI: 10.1016/j.jtct.2025.10.028 PMID: 41167523

Metabolomic Signatures of Relapse and Survival in AML Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.

Novitzky-Basso I, Xu C, Chiarello C, Reisz JA, D'Alessandro A, Bader GD, Mattsson J, Jones C

Hematology reports2026First authorOpen Access

DOI: 10.3390/hematolrep18020027 PMID: 42042192

Size Does Not Always Matter: Limited Impact of Donor-recipient Weight Difference on Outcomes of Adult Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplantation.

Chiarello C, Singhabahu S, Remberger M, Chen C, Moya TA, Al-Shaibani E, Gerbitz A, Kim DDH, Kumar R, Lam W, Law AD, Lipton JH, Michelis FV, Novitzky-Basso I, Viswabandya A, Mattsson J, Pasic I

Transplantation and cellular therapy2026

DOI: 10.1016/j.jtct.2025.10.002 PMID: 41062023

CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM - a single center analysis.

Stavi V, Chen C, Novitzky-Basso I, Remberger M, Law A, Gerbitz A, Viswabandya A, Kim DDH, Michelis FV, Pasic I, Kumar R, Lam W, Mattsson J, Lipton JH

Leukemia & lymphoma2026

DOI: 10.1080/10428194.2026.2668034 PMID: 42132052

Ferritin as a Pre-Transplant Biomarker for Post-Transplant Outcomes in Allogeneic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide.

Rodriguez-Rodriguez S, Chiarello C, Desai N, Remberger M, Chen C, Al-Shaibani E, Alfaro Moya T, Law AD, Pasic I, Viswabandya A, Michelis FV, Kim DDH, Kumar R, Mattsson J, Novitzky-Basso I

Transplantation and cellular therapy2026Senior author

DOI: 10.1016/j.jtct.2026.03.015 PMID: 41839367

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Igor Novitzky-Basso

Research

Latest papers

Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study.

Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia.

ATP2B1 expression identifies human hematopoietic stem cells with superior repopulation and self-renewal.

Frailty as a Prognostic Factor in Younger Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.

Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation.

Herpes Zoster Frequency and Adjuvanted Recombinant Zoster Vaccination after Allogeneic Hematopoietic Cell Transplantation.

Metabolomic Signatures of Relapse and Survival in AML Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.

Size Does Not Always Matter: Limited Impact of Donor-recipient Weight Difference on Outcomes of Adult Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplantation.

CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM - a single center analysis.

Ferritin as a Pre-Transplant Biomarker for Post-Transplant Outcomes in Allogeneic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide.

Frequent collaborators

Jonas Mattsson

Rajat Kumar

Auro Viswabandya

Ivan Pasic

Wilson Lam

Tommy Moya

Tommy Alfaro Moya

Eshrak Al-Shaibani

Mohamed Elemary

Tracy Stockley

Kristjan Paulson

Lambert Busque

Brian Leber

Dennis Kim

Michael Kennah

Shabbir Alibhai

Victoria Hall

Deepali Kumar

Fotios Michelis

Victor Ferreira

David Allan

Maria Perusini

Zhaolei Zhang

Christopher Lemieux